ABIOMED Stock Forecast NASDAQ:ABMD

Price Target and Analyst Ratings

Most Recent Rating

On August 06, 2021 "SVB Leerink" gave "$335.00 - $375.00" rating for ABMD. The price target was set to $348.86+5.3%.

Last 30 Days

Historical Ratings

Date	Rating	Action	Authority	Current Price	Target Price
2021-08-06	$335.00 - $375.00	Target Raised by	SVB Leerink	$345.88	$348.86+5.3%
2021-08-06	$360.00 - $410.00	Target Raised by	Deutsche Bank Aktiengesellschaft	$345.88	$348.86+5.3%
2021-07-20	$355.00 - $335.00	Target Lowered by	SVB Leerink	$323.59	$318.36+1.2%
2021-06-18	$360.00	Initiated by	Deutsche Bank Aktiengesellschaft	$318.57	$324.77→0.1%
2021-06-18	Buy	Initiated by	Deutsche Bank Aktiengesellschaft	$318.57	$360.00
2021-06-06	Hold	Reiterated by	SVB Leerink	$289.51
2021-01-29	Market Perform	Target Raised by	SVB Leerink	$348.25	$320.00 → $375.00
2021-01-29	Underweight	Target Raised by	Morgan Stanley	$348.25	$238.00 → $245.00
2021-01-28	Overweight	Target Raised by	Piper Sandler	$355.13	$350.00 → $425.00
2020-12-21	Positive - Market Perform	Target Raised by	SVB Leerink	$295.81	$280.00 → $320.00
2020-12-15	Underweight	Target Raised by	Morgan Stanley	$275.36	$217.00 → $238.00
2020-10-12	Market Perform	Target Lowered by	SVB Leerink	$277.85	$335.00 → $280.00
2020-08-07	Market Perform	Target Raised by	SVB Leerink	$310.82	$280.00 → $335.00
2020-08-07	Underweight	Target Raised by	Morgan Stanley	$310.82	$152.00 → $217.00
2020-07-13	Positive	Upgraded by	OTR Global	$264.55
2020-05-28	Market Perform	Target Raised by	SVB Leerink	$217.36	$195.00 → $225.00
2020-05-27	Hold	Downgraded by	BTIG Research	$207.76
2020-05-01	Underweight	Target Raised by	Morgan Stanley	$183.49	$149.00 → $152.00
2020-04-27	Outperform - Market Perform	Downgraded by	SVB Leerink	$163.47	$220.00 → $175.00

ABMD Stock Trend

The stock lies in the lower part of a wide and strong rising trend in the short term, and this may normally pose a very good buying opportunity. If the lower trend floor at $343.15 is broken, it will firstly indicate a slower rate of rising, but may also be an early warning for a trend shift.

Given the current short-term trend, the stock is expected to rise 16.47% during the next 3 months and, with a 90% probability hold a price between $399.67 and $447.20 at the end of this 3-month period.

WARNING: Trend forecast is still in the development phase and should be used with caution. Some cases might produce unexpected results such as negative prices at the end of the trend.

Data

Date	Bottom	Mid	Top
2021-09-22	$344.02	$364.42	$384.82
2021-09-23	$344.88	$365.28	$385.68
2021-09-24	$345.74	$366.14	$386.54
2021-09-27	$346.60	$367.00	$387.41
2021-09-28	$347.46	$367.87	$388.27
2021-09-29	$348.33	$368.73	$389.13
2021-09-30	$349.19	$369.59	$389.99
2021-10-01	$350.05	$370.45	$390.85
2021-10-04	$350.91	$371.31	$391.72
2021-10-05	$351.77	$372.18	$392.58
2021-10-06	$352.64	$373.04	$393.44
2021-10-07	$353.50	$373.90	$394.30
2021-10-08	$354.36	$374.76	$395.16
2021-10-11	$355.22	$375.62	$396.03
2021-10-12	$356.08	$376.49	$396.89
2021-10-13	$356.95	$377.35	$397.75
2021-10-14	$357.81	$378.21	$398.61
2021-10-15	$358.67	$379.07	$399.47
2021-10-18	$359.53	$379.93	$400.34
2021-10-19	$360.39	$380.80	$401.20
2021-10-20	$361.26	$381.66	$402.06
2021-10-21	$362.12	$382.52	$402.92
2021-10-22	$362.98	$383.38	$403.78
2021-10-25	$363.84	$384.24	$404.65
2021-10-26	$364.70	$385.11	$405.51
2021-10-27	$365.57	$385.97	$406.37
2021-10-28	$366.43	$386.83	$407.23
2021-10-29	$367.29	$387.69	$408.09
2021-11-01	$368.15	$388.55	$408.96
2021-11-02	$369.01	$389.42	$409.82

About ABIOMED

ABIOMED ABIOMED, Inc. engages in the research, development, and sale of medical devices to assist or replace the pumping function of the failing heart. It also provides continuum of care to heart failure patients. The company offers Impella 2.5 catheter, a percutaneous micro heart pump with integrated motor and sensors for use in interventional cardiology; Impella CP that provides partial circulatory support using an extracorporeal bypass control unit; I... Read more

Golden Star Signal

This unique signal uses moving averages and adds special requirements that convert the very good Golden Cross into a Golden Star.

This signal is rare and, in most cases, gives substantial returns. From 10 000+ stocks usually only a few will trigger a Golden Star Signal per day!

Get access to Golden Star list now!